Comparative assessment of patients' admission to urology departments during and before the COVID-19 pandemic: a retrospective cohort study
Abstract
Aim: To determine the diseases that presented to the urology department during the COVID-19 pandemic and for hospital-based comparison with the diseases that presented in the same period of the previous year.
Material and Method: In this retrospective follow-up study, patients who were admitted to the tertiary university hospital and secondary state hospital urology departments between April-July 2019 and April-July 2020 were included in the study. We searched the health administrative data using the International Classification of Diseases-10 codes. The number and variety of patients who were admitted to the urology departments in the same months of 2019 and 2020 were compared.
Results: In both hospitals, the total number of admissions decreased during the pandemic in 2020 compared to the pre-pandemic year. Also, elective admissions decreased in 2020 compared to the pre-pandemic year (p <0.001). In a significant part of the urological disease group, the decrease in the number of admissions was found to be higher for the second-level center than for the tertiary center hospital.
Conclusion: We documented that uro-oncology outpatient admissions could continue during the COVID-19 pandemic in a university hospital- not primarily served as a pandemic hospital- by taking preventive measures and prioritizing healthcare personnel and patient safety.
Keywords
References
- Huang C, Wang Y, Li X, Ren L, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506.
- Stensland KD, Morgan TM, Moinzadeh A, et al. Considerations in the triage of urologic surgeries during the COVID-19 pandemic. Eur Urol 2020; 77: 663–6.
- Ribal MJ, Cornford P, Briganti A, et al. European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era. Eur Urol 2020;78: 21–8.
- Coronavirus Disease (COVID-19) Situation Reports [Internet].[cited 2021 Mar 28]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports.
- Wong J, Goh QY, Tan Z, et al. Preparing for a COVID-19 pandemic: a review of operating room outbreak response measures in a large tertiary hospital in Singapore. Can J Anaesth 2020; 67: 732–45.
- Keles E, Akis S, Kemal Ozturk U, Eser Ozyurek S, Api M. Gynecological surgeries during the COVID-19 pandemic in Turkey. Int J Gynaecol Obstet 2020; 151: 141-4.
- Tefik T, Guven S, Villa L, et al. Urolithiasis Practice Patterns Following the COVID-19 Pandemic: Overview from the EULIS Collaborative Research Working Group. Eur Urol 2020; 78: e21–4.
- Proietti S, Gaboardi F, Giusti G. Endourological stone management in the era of the COVID-19. Eur Urol 2020; 78: 131–3.
- Puliatti S, Eissa A, Eissa R, et al. COVID-19 and urology: a comprehensive review of the literature. BJU Int 2020; 125: E7–E14.
- Flammia S, Salciccia S, Tufano A, Busetto GM, Ricciuti GP, Sciarra A. How urinary stone emergencies changed in the time of COVID-19? Urolithiasis 2020; 48: 467-9.
- Al-Shamsi HO, Alhazzani W, Alhuraiji A, et al. A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group. Oncologist 2020; 25: e936-45.
- Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020; 21: 335-7.
- Wang H, Zhang L. Risk of COVID-19 for patients with cancer. Lancet Oncol 2020; 21: e181.
- Zequi SC, Abreu D. Consideration in the management of renal cell carcinoma during the COVID-19 pandemic. Int Braz J Urol 2020; 46: 69–78.
- Gravas S, Fournier G, Oya M, et al. Prioritising Urological Surgery in the COVID-19 Era: A Global Reflection on Guidelines. Eur Urol Focus 2020; 6: 1104–10.
- Professionals S-O. EAU Guidelines: Non-muscle-invasive Bladder Cancer [Internet]. Uroweb. [cited 2020 Dec 5]. Available from: https://uroweb.org/guideline/non-muscle-invasive-bladder-cancer/
- Esperto F, Pang KH, Albisinni S, Papalia R, Scarpa RM. Bladder cancer at the time of COVID-19 outbreak. Int Braz J Urol 2020; 46: 62–8.
- Darlington CD, Mammen RJ, Mammen KJ. COVID-19 and its impact on genitourinary malignancies. Indian J Urol 2020; 36: 163–170.
- Carneiro A, Wroclawski ML, Nahar B, et al. Impact of the COVID-19 pandemic on the urologist’s clinical practice in Brazil: a management guideline proposal for low- and middle-income countries during the crisis period. Int Braz J Urol 2020; 46: 501–10.
- Nappi L, Ottaviano M, Rescigno P, et al. Italian Germ Cell Cancer Group (IGG) ERN-EURACAN Domain G3 Genitourinary Medical Oncologists of Canada (GUMOC) Management of germ cell tumors during the outbreak of the novel coronavirus disease-19 pandemic: a survey of international expertise centers. Oncologist 2020; 25: 1509–15.
- Bozkurt O, Sen V, Irer B, et al. Nation-wide analysis of the impact of the Covid-19 pandemic on daily urology practice in Turkey. Int J Clin Pract 2021; 75: e13735.
- Icarra V, Novara G, Abrate A, et al. Urology practice during the COVID-19 pandemic. Minerva Urol Nefrol 2020; 72: 369-75.
- Karagöz MA, Gül A, Borg C, et al. Influence of COVID-19 pandemic on sexuality: a cross-sectional study among couples in Turkey. Int J Impot Res 2020; 33: 815-23.
Abstract
Keywords
References
- Huang C, Wang Y, Li X, Ren L, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506.
- Stensland KD, Morgan TM, Moinzadeh A, et al. Considerations in the triage of urologic surgeries during the COVID-19 pandemic. Eur Urol 2020; 77: 663–6.
- Ribal MJ, Cornford P, Briganti A, et al. European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era. Eur Urol 2020;78: 21–8.
- Coronavirus Disease (COVID-19) Situation Reports [Internet].[cited 2021 Mar 28]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports.
- Wong J, Goh QY, Tan Z, et al. Preparing for a COVID-19 pandemic: a review of operating room outbreak response measures in a large tertiary hospital in Singapore. Can J Anaesth 2020; 67: 732–45.
- Keles E, Akis S, Kemal Ozturk U, Eser Ozyurek S, Api M. Gynecological surgeries during the COVID-19 pandemic in Turkey. Int J Gynaecol Obstet 2020; 151: 141-4.
- Tefik T, Guven S, Villa L, et al. Urolithiasis Practice Patterns Following the COVID-19 Pandemic: Overview from the EULIS Collaborative Research Working Group. Eur Urol 2020; 78: e21–4.
- Proietti S, Gaboardi F, Giusti G. Endourological stone management in the era of the COVID-19. Eur Urol 2020; 78: 131–3.
- Puliatti S, Eissa A, Eissa R, et al. COVID-19 and urology: a comprehensive review of the literature. BJU Int 2020; 125: E7–E14.
- Flammia S, Salciccia S, Tufano A, Busetto GM, Ricciuti GP, Sciarra A. How urinary stone emergencies changed in the time of COVID-19? Urolithiasis 2020; 48: 467-9.
- Al-Shamsi HO, Alhazzani W, Alhuraiji A, et al. A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group. Oncologist 2020; 25: e936-45.
- Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020; 21: 335-7.
- Wang H, Zhang L. Risk of COVID-19 for patients with cancer. Lancet Oncol 2020; 21: e181.
- Zequi SC, Abreu D. Consideration in the management of renal cell carcinoma during the COVID-19 pandemic. Int Braz J Urol 2020; 46: 69–78.
- Gravas S, Fournier G, Oya M, et al. Prioritising Urological Surgery in the COVID-19 Era: A Global Reflection on Guidelines. Eur Urol Focus 2020; 6: 1104–10.
- Professionals S-O. EAU Guidelines: Non-muscle-invasive Bladder Cancer [Internet]. Uroweb. [cited 2020 Dec 5]. Available from: https://uroweb.org/guideline/non-muscle-invasive-bladder-cancer/
- Esperto F, Pang KH, Albisinni S, Papalia R, Scarpa RM. Bladder cancer at the time of COVID-19 outbreak. Int Braz J Urol 2020; 46: 62–8.
- Darlington CD, Mammen RJ, Mammen KJ. COVID-19 and its impact on genitourinary malignancies. Indian J Urol 2020; 36: 163–170.
- Carneiro A, Wroclawski ML, Nahar B, et al. Impact of the COVID-19 pandemic on the urologist’s clinical practice in Brazil: a management guideline proposal for low- and middle-income countries during the crisis period. Int Braz J Urol 2020; 46: 501–10.
- Nappi L, Ottaviano M, Rescigno P, et al. Italian Germ Cell Cancer Group (IGG) ERN-EURACAN Domain G3 Genitourinary Medical Oncologists of Canada (GUMOC) Management of germ cell tumors during the outbreak of the novel coronavirus disease-19 pandemic: a survey of international expertise centers. Oncologist 2020; 25: 1509–15.
- Bozkurt O, Sen V, Irer B, et al. Nation-wide analysis of the impact of the Covid-19 pandemic on daily urology practice in Turkey. Int J Clin Pract 2021; 75: e13735.
- Icarra V, Novara G, Abrate A, et al. Urology practice during the COVID-19 pandemic. Minerva Urol Nefrol 2020; 72: 369-75.
- Karagöz MA, Gül A, Borg C, et al. Influence of COVID-19 pandemic on sexuality: a cross-sectional study among couples in Turkey. Int J Impot Res 2020; 33: 815-23.
Details
| Primary Language | English |
|---|---|
| Subjects | Health Care Administration |
| Journal Section | Original Article |
| Authors | |
| Publication Date | March 27, 2023 |
| Published in Issue | Year 2023 Volume: 6 Issue: 2 |
Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS].
The Directories (indexes) and Platforms we are included in are at the bottom of the page.
Note: Our journal is not WOS indexed and therefore is not classified as Q.
You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/2316/file/4905/show
The indexes of the journal are ULAKBİM TR Dizin, Index Copernicus, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, EuroPub, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, etc.
|
|
|
| |
|
|
|
|
The platforms of the journal are Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons, etc.
|
|
|
|
|
|
Our Journal using the DergiPark system indexed are;
Ulakbim TR Dizin, Index Copernicus, ICI World of Journals, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, OpenAIRE, MIAR, EuroPub, WorldCat (OCLC), DOAJ, Türkiye Citation Index, Türk Medline Index, InfoBase Index
Our Journal using the DergiPark system platforms are;
Journal articles are evaluated as "Double-Blind Peer Review".
Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user. https//dergipark.org.tr/tr/pub/jhsm/page/9535
Journal charge policy https://dergipark.org.tr/tr/pub/jhsm/page/10912
Editor List for 2022
Assoc. Prof. Alpaslan TANOĞLU (MD)
Prof. Aydın ÇİFCİ (MD)
Prof. İbrahim Celalaettin HAZNEDAROĞLU (MD)
Prof. Murat KEKİLLİ (MD)
Prof. Yavuz BEYAZIT (MD)
Prof. Ekrem ÜNAL (MD)
Prof. Ahmet EKEN (MD)
Assoc. Prof. Ercan YUVANÇ (MD)
Assoc. Prof. Bekir UÇAN (MD)
Assoc. Prof. Mehmet Sinan DAL (MD)
Our journal has been indexed in DOAJ as of May 18, 2020.
Our journal has been indexed in TR-Dizin as of March 12, 2021.
Articles published in the Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.